Researchers are betting that new tools can cut drug discovery from five years to six months
Biomedical sciences
SRI research scientists discuss new opportunities for large-scale data collection through consumer sleep technology
Consumer sleep technology (CST) is a fast-paced industry, and little is known about the accuracy and reliability of consumer sleep-tracking devices
Bedtime virtual reality intervention may improve teens’ sleep
New research shows immersive VR and breathing techniques helps improve overall sleep quality in adolescents with insomnia
What if you gave cancer the measles?
SRI has created a novel platform that could significantly expand the benefit of immunotherapies by “infecting” cancer cells
SRI International Awarded Contract Worth Up to $100M from National Institute of Allergy and Infectious Diseases for Radiation/Nuclear Medical Countermeasures
Grant extends SRI’s long history of collaborations with the National Institutes of Health
Do you know who I am?
June 2020 – Decoded Health
SRI’s tech enables spin-off Decoded Health, and global collaboration with synthetic-chemistry system, SynFini™.
Developing the next generation of PCR diagnostics for point-of-contact screening
SRI International investigator awarded National Science Foundation grant for development of a revolutionary point of contact diagnostic for infectious diseases The current world-wide COVID-19 pandemic underscores the need for rapid and widespread screening for emerging infectious agents. As emerging infectious diseases can spread rapidly, government agencies have made developing detection technologies a priority. To explore […]
Nathan Collins talks about the SynFini™ automated chemistry platform (Part 1)
Nathan Collins joins host Reenita Hora to discuss how the SynFini automated chemistry platform is accelerating drug development and discovery. Learn more about SynFini at: https://www.sri.com/case-studies/synfini. Nathan Collins is the Chief Strategy Officer of SRI Biosciences in Menlo Park, CA. In part one of this episode of The Dish TV they discuss the processes and […]
Nathan Collins talks about integrating AI with the SynFini™ Platform (Part 2)
Nathan Collins joins host Reenita Hora to discuss how integrating AI with the SynFini automated chemistry platform is poised to shape the future of drug discovery and development. Learn more about SynFini at: https://www.sri.com/case-studies/synfini Nathan Collins is the Chief Strategy Officer of SRI Biosciences in Menlo Park, CA. In part two of this episode of […]
COVID-19 Puts Spotlight on Artificial Intelligence, Including SRI’s Automated System, SynFini
April 2020 – SynFini™ Automated Chemistry Platform
Revolutionizing drug design and discovery
SRI Introduces Novel Synthetic Chemistry System at SLAS 2020
SRI Biosciences Chief Strategy Officer Nathan Collins, Ph.D., will present an overview of SynFini, the company’s fully automated, end-to-end synthetic-chemistry system, at the Society for Laboratory Automation & Screening (SLAS) 2020 Conference. The SynFini platform is designed to accelerate chemical discovery and development, and thereby bring new drugs to the clinic more quickly and affordably. […]
